CompletedNot Applicable

Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery

El Salvador8 participantsStarted 2023-09-18

Plain-language summary

Subjects who had a bilateral age-related cataract surgery with the IOLs AT ELANA 841P and AT LISA tri 839MP will be contacted and invited to attend a postoperative visit more than one year after the surgery

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult patient of any gender;
✓. Patients who had an uncomplicated (no intra-operative complication) age-related cataract surgery
✓. Currently implanted with an IOL model AT ELANA 841P into the capsular bag in one eye and with the IOL model AT LISA tri 839MP into the capsular bag of the other eye.
✓. The postoperative visit was scheduled to be conducted more than one year after the second eye surgery.
✓. Given written informed consent by patient.

Exclusion criteria

✕. Patients unable to meet the limitations of the protocol or likely of non-cooperation during the study
✕. Patient whose freedom is impaired by administrative or legal order
✕. Concurrent participation in another drug or device investigation that could confound the outcome of this investigation.

What they're measuring

Monocular Corrected Distance Visual Acuity (CDVA)

Timeframe: 12 to 24 months after cataract surgery

Slit Lamp Examination

Timeframe: 12 to 24 months after cataract surgery

Trial details

NCT IDNCT06192901

SponsorCarl Zeiss Meditec AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-09-22

View on ClinicalTrials.gov More Senile Cataract trials